- Advertisement -
- Advertisement -
- Advertisement -

Find a job

Subscribe for free

All things Pharma

Advanced prostate cancer drug discovery

Scientists have discovered a genetic aberration found in some prostate cancers, that could allow more men to be successfully treated with an existing targeted...
- Advertisement -
- Advertisement -
- Advertisement -

Four tips for preparing your 2022 marketing strategy

I’ve spent the past two decades working in marketing roles within the global pharma...

Improving the patient treatment pathway

A clear, appropriate and best practice-based patient treatment pathway is crucial. Explore how to...

Insights from The World Orphan Drug Congress: Advancing orphan drugs and rare diseases

Maurice Leonard, Medical Affairs Director at Uniphar shares his key takeaways from The World Orphan Drug Congress, Boston. As a company dedicated to enabling...

Meeting on the Med: Navigating rapid growth of the cell and gene therapy sector

Experience is key in emerging industries. The Uniphar team joined over 500 industry experts at the Alliance of Regenerative Medicine’s Meeting on the Med to...

The impact of EU pharmaceutical reform

Uniphar was delighted to welcome European industry leaders to Zurich to debate the proposed EU pharmaceutical legislation reform, and incoming HTA reform. The conversation...

Subscribe for FREE

View all issues

- Advertisement -
- Advertisement -

NHS launches new BRCA gene testing programme

Tens of thousands of people with Jewish ancestry, who are more likely to carry a genetic fault that can increase the risk of developing...

Janssen seeks approval for its multiple myeloma treatment

Janssen has announced the submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) seeking approval of talquetamab for the treatment of patients with relapsed or refractory multiple myeloma (RRMM). Talquetamab is an investigational, off-the-shelf (ready to...

New President and General Manager for Eli Lilly

Eli Lilly & Company has appointed Christopher Stokes as President and General Manager for...

Guy Oliver appointed General Manager for Bristol Myers Squibb

Guy Oliver has been appointed as General Manager for Bristol Myers Squibb, leading the...

Ipsen appoints Ioana Parsons as UK and Ireland General Manager

Ipsen has announced the appointment of Ioana Parsons as General Manager of the company’s...


View all roles


On demand: Maximising pharma’s commercial impact with brand optimisation

Uniphar’s Client Solutions Director, Mark Ward, and Director of Consulting, Nick Bartlett, chair a Pf Media and Uniphar webinar, ‘Maximising pharma’s commercial impact with...


Sign up to receive our digital newsletter, for all the essential headlines, Jobs of the Week and thought-provoking features.

Claim my free subscription